Skip to content

Group Exercise in Cancer Patients Under Active Treatment: Feasibility Pilot Study.

Group Exercise in Cancer Patients Under Active Treatment: Feasibility Pilot Study.

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06825429
Enrollment
50
Registered
2025-02-13
Start date
2025-03-31
Completion date
2027-09-30
Last updated
2025-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplastic Disease

Brief summary

The aim of this study to investigate the feasibility in hospital reality, of a group exercise program for oncology patients under active treatment and evaluate its impact on some outcomes considered relevant from both clinical and subjective point of view.

Detailed description

The intervention will consist of EFG sessions lasting 45 minutes each, twice a week for 12 weeks to be carried out in the gym of the Rehabilitation Day Hospital. Each 45-minute session includes an initial relaxation/stretching phase, simple aerobic exercises, muscle strengthening exercises, balance exercises, and will be led by a physiotherapist. The exercises proposed to the group with ECOG 2 will be less intense and of less difficulty with the aim of adapting the activity to patients with a lower performance status (see appendix 4.5, V2, 07/10/2024). The groups will consist of a minimum of five patients and a maximum of ten. Patients will also be stimulated to perform physical activity at home to a total of 150 minutes per week. Patients will be assessed at baseline (T0), at the end of the intervention (T1,12 weeks) and 6 months after the start of the intervention (T2).

Interventions

PROCEDUREexercise programme for group with ECOG 0-1

exercise programme for group with ECOG 2

PROCEDUREexercise programme for ECOG 2 group

this intervention shall be proportionated to the ECOG status of the group

Sponsors

IRCCS Azienda Ospedaliero-Universitaria di Bologna
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Single-centre, uncontrolled interventional feasibility study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* neoplastic tumor * age\>= 18 * prognosis\> 12 months * ECOG \<=2 * Walking with/ without aids * clinically stable * signed informed consent * Patients with bone metastases with ECOG from 0-1 suitable results

Exclusion criteria

* sensory deficits who cannot perform physical exercise * cognitive impairment that compromises collaboration and questionnaire filling * patients with pathologies (e.g. neurological, psychiatric) that do not allow the obtaining of valid informed consent

Design outcomes

Primary

MeasureTime frameDescription
adherence to the group exercise programmethrough study completion, an average of 2 yearsoverall adherence to the group exercise programme \> 40%
Frequencythrough study completion, an average of 2 yearsThe frequency of at least 70% of the exercise sessions foreseen by the programme.

Secondary

MeasureTime frameDescription
QoLthrough study completion, an average of 2 yearsQuestionnaire in which patients have to describe quality of life during study treatment
tolerance to effortthrough study completion, an average of 2 yearsThe effect of the EFG program on mood tone and physical function

Contacts

Primary ContactBesa Kopliku, MD
besa.kopliku@aosp.bo.it0512142285
Backup ContactLetizia Circosta, PT
letizia.circosta@aosp.bo.it3383394823

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026